NDC 0143-9935-91 - Cefotaxime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9935
- Requested NDC
- 0143-9935-91
- Package NDCs from labels
- 0143-9935-01, 0143-9935-91
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2024-04-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefotaxime - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2024-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9935-01 | Cefotaxime | 1 in 1 PACKAGE | INJECTION | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9935-01 | EA - Each | 0143-9935 | e75c7c19-3c60-4f5d-b183-0848875b43bb | 1 | 2015-12-02 |
| 0143-9935-91 | EA - Each | 0143-9935 | e8dfeca5-2e69-4eba-9faa-ce3bd9d5250b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFOTAXIME SODIUM | ACTIVE INGREDIENT | 258J72S7TZ | CEFOTAXIME INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 7 | |
| CEFOTAXIME | ACTIVE MOIETY | N2GI8B1GK7 | CEFOTAXIME INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefotaxime | CEFOTAXIME INJECTION | SteriMax Inc. | 8efe3bd0-c43a-2bd6-e053-2a95a90a92fa | 2026-06-15 | 258J72S7TZ | |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ed23b6bc-32c7-4c50-a53d-313ae78e5623 | 2024-04-11 | Warnings, Adverse reactions | 258J72S7TZ |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 | 2024-04-11 | Warnings, Adverse reactions | ANDA065071 0143-9935-01 0143-9935 309065 e25af43f-54cb-4526-a8a5-6bef0a7939c7 ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 258J72S7TZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.